[Hyperaggregation effects of thrombolytic enzymes].
D001778:Blood Coagulation Disorders / Q000188:drug therapy; D004176:Dipyridamole / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects*
D005343:Fibrinolytic Agents; D004176:Dipyridamole; D006493:Heparin
Effets hyper-agrégants des enzymes thrombolytiques